The anti‐C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID‐19
Abstract Recently, we reported the phase II portion of the adaptive phase II/III PANAMO trial exploring potential benefit and safety of selectively blocking C5a with the monoclonal antibody vilobelimab (IFX‐1) in patients with severe coronavirus disease 2019 (COVID‐19). The potent anaphylatoxin C5a...
Guardat en:
Autors principals: | Alexander P. J. Vlaar (Autor), Endry H. T. Lim (Autor), Sanne deBruin (Autor), Simon Rückinger (Autor), Korinna Pilz (Autor), Matthijs C. Brouwer (Autor), Ren‐Feng Guo (Autor), Leo M. A. Heunks (Autor), Matthias H. Busch (Autor), Pieter vanPaassen (Autor), Niels C. Riedemann (Autor), Diederik van deBeek (Autor) |
---|---|
Format: | Llibre |
Publicat: |
Wiley,
2022-04-01T00:00:00Z.
|
Matèries: | |
Accés en línia: | Connect to this object online. |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Ítems similars
-
Host genetic variability and pneumococcal disease: a systematic review and meta-analysis
per: Anne T. Kloek, et al.
Publicat: (2019) -
Streptococcus suis Meningitis: A Systematic Review and Meta-analysis.
per: Anusha van Samkar, et al.
Publicat: (2015) -
Symphony No. 5 in C minor Opus 67
per: Beethoven, Ludwig van, 1770-1827 -
Symphony No. 5 in C minor, Opus 67
per: Beethoven, Ludwig van, 1770-1827 -
Simultaneous occurrence of C5 vertebral angioma and C5-C6 discopathy and stenosis - case report
per: Agnieszka Nowacka, et al.
Publicat: (2021)